Dr. Rahul Kushwah reports

PREDICTMEDIX AI ACCELERATES CORPORATE EXPANSION DURING MONTH-LONG INTERNATIONAL CAMPAIGN

Predictmedix AI Inc. has just returned from a fruitful month of international endeavours, during which the company achieved significant milestones in corporate development.

Throughout its overseas venture, Predictmedix AI has made remarkable strides, reinforcing its commitment to innovation and excellence. These advancements encompass various domains and include:

• Strategic alliances: Predictmedix AI has initiated multiple partnerships designed to drive business development across diverse verticals, with a strong focus on the health care sector. These partnerships are poised to redefine how artificial-intelligence-driven solutions impact the industry and beyond.
• Government collaborations: Building on its commitment to regulatory alignment and government initiatives, Predictmedix AI has established vital partnerships with key government organizations to promote innovation and compliance.
• Enhanced health care engagement: During its overseas tenure, Predictmedix AI continued to deepen its engagement within the health care sector, demonstrating its continuing dedication to transforming patient care and diagnosis using state-of-the-art AI technologies.
• Diversified opportunities: Predictmedix AI has explored new opportunities in non-health-care verticals, further expanding its footprint and leveraging its AI expertise to contribute to various industries.
• Key talent acquisition: The company has recruited key individuals with exceptional skills and experience, strategically enhancing the team to accelerate business development efforts.
• Certifications for health care: In response to client requirements for commercial orders, Predictmedix AI is actively pursuing Bureau of Indian Standards (BIS) and Central Drugs Standard Control Organization (CDSCO) certifications to ensure the quality and compliance of its health care solutions.

Dr. Rahul Kushwah, chief operating officer of Predictmedix AI, expressed his enthusiasm: "Our overseas campaign has provided a unique platform to reaffirm our unwavering commitment to innovation, regulatory alignment and the relentless pursuit of excellence, including many confidential discussions and arrangements. As situations continue to evolve, we will make appropriate disclosures."

Predictmedix AI is also pleased to confirm the company has established a corporate address in San Francisco, United States.

These corporate developments emphasize Predictmedix AI's mission to revolutionize AI applications across various verticals, establishing the company as a global leader in advanced AI technologies.

The company has also entered into agreements with two consultants who have provided services to the company related to the development of the company's technologies. As consideration for the services, the company will issue one million common shares to each consultant, for a total issuance of two million common shares.

About Predictmedix AI Inc.

Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally. The company's Safe Entry stations -- powered by a proprietary artificial intelligence (AI) -- use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes.

We seek Safe Harbor.